Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT) - ACT Investigators (Circulation, 2011)
doi: 10.1161/CIRCULATIONAHA.111.038943